A detailed history of First Trust Advisors LP transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, First Trust Advisors LP holds 12,875 shares of HQL stock, worth $182,438. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,875
Previous 12,362 4.15%
Holding current value
$182,438
Previous $175,000 10.86%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$14.26 - $15.78 $7,315 - $8,095
513 Added 4.15%
12,875 $194,000
Q2 2024

Aug 13, 2024

BUY
$12.79 - $14.27 $24,480 - $27,312
1,914 Added 18.32%
12,362 $175,000
Q1 2024

May 13, 2024

BUY
$13.38 - $14.33 $139,794 - $149,719
10,448 New
10,448 $142,000
Q3 2023

Nov 13, 2023

BUY
$12.38 - $13.69 $130,571 - $144,388
10,547 New
10,547 $131,000
Q3 2022

Nov 14, 2022

SELL
$13.39 - $16.31 $17,514 - $21,333
-1,308 Reduced 7.12%
17,060 $233,000
Q2 2022

Aug 12, 2022

SELL
$13.11 - $17.02 $8,573 - $11,131
-654 Reduced 3.44%
18,368 $261,000
Q1 2022

May 13, 2022

SELL
$15.35 - $19.29 $30,116 - $37,846
-1,962 Reduced 9.35%
19,022 $315,000
Q4 2021

Feb 08, 2022

BUY
$18.5 - $21.59 $12,487 - $14,573
675 Added 3.32%
20,984 $404,000
Q3 2021

Nov 15, 2021

BUY
$20.27 - $22.67 $27,364 - $30,604
1,350 Added 7.12%
20,309 $422,000
Q2 2021

Aug 16, 2021

BUY
$19.14 - $21.44 $12,919 - $14,472
675 Added 3.69%
18,959 $406,000
Q1 2021

May 14, 2021

SELL
$19.31 - $22.07 $39,102 - $44,691
-2,025 Reduced 9.97%
18,284 $360,000
Q4 2020

Feb 02, 2021

SELL
$16.8 - $20.21 $22,680 - $27,283
-1,350 Reduced 6.23%
20,309 $401,000
Q3 2020

Nov 05, 2020

SELL
$16.71 - $19.06 $22,558 - $25,731
-1,350 Reduced 5.87%
21,659 $381,000
Q1 2020

May 06, 2020

SELL
$12.22 - $17.99 $32,994 - $48,572
-2,700 Reduced 10.5%
23,009 $345,000
Q4 2019

Feb 03, 2020

BUY
$14.63 - $17.84 $39,501 - $48,168
2,700 Added 11.73%
25,709 $448,000
Q3 2019

Nov 04, 2019

BUY
$15.09 - $17.09 $53,433 - $60,515
3,541 Added 18.19%
23,009 $347,000
Q2 2019

Jul 30, 2019

BUY
$15.54 - $17.47 $302,532 - $340,105
19,468 New
19,468 $328,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.